HRG has been shown to induce the interaction of HER2 with HER3 and HER4, resulting in increased tyrosine phosphorylation of HER2 in breast cancer cells and, thus, increased metastasis by enhancing tumor cell invasion and intravasation in vivo [44]. The gene discussed is ERBB3; the disease is breast carcinoma.